127 related articles for article (PubMed ID: 7770639)
21. Bilioenteric anastomosis reverses hyperkinetic circulation in bile duct-ligated cirrhotic rats.
Jalink D; Urbanski SJ; Lee SS
J Hepatol; 1996 Dec; 25(6):924-31. PubMed ID: 9007722
[TBL] [Abstract][Full Text] [Related]
22. The effects of ursodeoxycholic acid in patients with severe obstructive jaundice after drainage procedure.
Hsu SH; Lu CL; Chan CY; Lin SH; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Sep; 60(3):142-6. PubMed ID: 9419950
[TBL] [Abstract][Full Text] [Related]
23. The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation.
Sokolovic D; Nikolic J; Kocic G; Jevtovic-Stoimenov T; Veljkovic A; Stojanovic M; Stanojkovic Z; Sokolovic DM; Jelic M
Drug Chem Toxicol; 2013 Apr; 36(2):141-8. PubMed ID: 22385135
[TBL] [Abstract][Full Text] [Related]
24. [Ursodeoxycholic acid promotes liver regeneration after partial hepatectomy in bile duct obstructive rats].
Xu M; Han B; Xue L; Gong J
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):103-5. PubMed ID: 11983124
[TBL] [Abstract][Full Text] [Related]
25. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
26. [Effects of urso-deoxycholic acid (UDCA) on alpha-naphthyl-isothiocyanate (ANIT) induced intrahepatic cholestasis in rats].
Ando M
Nihon Shokakibyo Gakkai Zasshi; 1992 Oct; 89(10):2586-93. PubMed ID: 1404970
[TBL] [Abstract][Full Text] [Related]
27. Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis.
Di Guida F; Pirozzi C; Magliocca S; Santoro A; Lama A; Russo R; Nieddu M; Burrai L; Boatto G; Mollica MP; Sodano F; Lazzarato L; Chegaev K; Meli R; Raso GM; Rimoli MG
Mol Pharm; 2018 Jan; 15(1):21-30. PubMed ID: 29140706
[TBL] [Abstract][Full Text] [Related]
28. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
29. The effects of nitric oxide synthase blockers on mesenteric blood flow with bile duct ligation.
Yuksel BC; Tanriverdi P; Ozel H; Avsar FM; Topaloglu S; Iskit AB
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxix-ccxxi. PubMed ID: 15244184
[TBL] [Abstract][Full Text] [Related]
30. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
[TBL] [Abstract][Full Text] [Related]
32. Rat renal function four days after bile-duct ligation: effects of indomethacin and vasoactive agents.
Monasterolo LA; Ochoa JE; Elías MM
Ren Fail; 2002 Mar; 24(2):111-26. PubMed ID: 12071586
[TBL] [Abstract][Full Text] [Related]
33. Ursodeoxycholic acid choleresis: relationship to biliary HCO-3 and effects of Na+-H+ exchange inhibitors.
Renner EL; Lake JR; Cragoe EJ; Van Dyke RW; Scharschmidt BF
Am J Physiol; 1988 Feb; 254(2 Pt 1):G232-41. PubMed ID: 2831731
[TBL] [Abstract][Full Text] [Related]
34. Allopurinol and glutamine attenuate bacterial translocation in chronic portal hypertensive and common bile duct ligated growing rats.
Schimpl G; Pesendorfer P; Steinwender G; Feierl G; Ratschek M; Höllwarth ME
Gut; 1996 Jul; 39(1):48-53. PubMed ID: 8881808
[TBL] [Abstract][Full Text] [Related]
35. Treatment with recombinant bactericidal/permeability-increasing protein to prevent endotoxin-induced mortality in bile duct-ligated rats.
Kimmings AN; van Deventer SJ; Obertop H; Gouma DJ
J Am Coll Surg; 1999 Oct; 189(4):374-9. PubMed ID: 10509463
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
[TBL] [Abstract][Full Text] [Related]
37. Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.
Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; D'Amato G; Del Prete MS; Orlando F; Kamysz W; Lukasiak J; Saba V; Scalise G
Gut; 2003 Jun; 52(6):874-8. PubMed ID: 12740345
[TBL] [Abstract][Full Text] [Related]
38. Increased renal susceptibility to gentamicin in the rat with obstructive jaundice. Role of lipid peroxidation.
Tajiri K; Miyakawa H; Marumo F; Sato C
Dig Dis Sci; 1995 May; 40(5):1060-4. PubMed ID: 7729264
[TBL] [Abstract][Full Text] [Related]
39. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
[TBL] [Abstract][Full Text] [Related]
40. Endotoxemia and cholestasis.
Roughneen PT; Kumar SC; Pellis NR; Rowlands BJ
Surg Gynecol Obstet; 1988 Sep; 167(3):205-10. PubMed ID: 3413650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
